SYNCROVEX - Key Persons

Jackie has more than 30 years experience working in the Pharmaceutical industry. She graduated from Edinburgh University in 1987 with a BSc (Hons) in Pharmacology. She began her career at Inveresk Research (now Charles River Laboratories), initially as a Study Director in ADME, working both in preclinical and Phase I clinical trials. She later moved to the role of Quality Improvement Specialist; working between Quality Assurance and operational teams to identify and implement solutions in response to issues flagged at audit. In 1998 Jackie took up a post at Quintiles as Head of Project Administration/Management, which involved managing the financial and budgetary aspects, initially for the Pharmacology department but later also for the Toxicology and Drug Metabolism groups. During that time, she was also Head of the Safety Pharmacology and Efficacy CNS Groups. Subsequently she focussed her business and project management skills on the Department of Toxicology, becoming Head of Toxicology Operations and then Director of Toxicology. During that time the Quintiles Preclinical facility was acquired by Aptuit, Jackie had a key role in managing the transition into the new organisation. In 2008 Jackie left Aptuit to begin working as an independent freelance consultant working with companies ranging from start up companies, through several small to mid-size pharma companies, to major CROs providing business support and management expertise in a range of areas including preclinical and clinical development. Jackie joined Syncrovex in Dec 2015 to expand Syncrovex's project management offering and to include her business support expertise. In addition to her industry roles, Jackie has completed lean six sigma yellow belt training, achieving 100% in the final exam. Jackie's full career history can be viewed on her LinkedIn profile via this link: Jackie LinkedIn Experience Profile

Rob has 30 years experience working in the Pharmaceutical industry. While working at Amersham International (now GE) as a lab technician in product development he completed an HNC in Chemistry. He then went on to Bradford University from where he graduated in 1991 with a BSc Hons in Biomedical Sciences. Rob then took up a position at Inveresk Research (now Charles River Laboratories), initially as a Study Director in preclinical ADME, and later becoming a Scientific Manager. In 1999 Rob moved to Scotia Pharmaceuticals, as a project manager in non-clinical development. In this role he was involved in the development of new chemical entities which involved devising pre-clinical programmes suitable for fast-track development. He also gained experience in preparation of non-clinical regulatory documentation. During his time at Scotia, Rob had significant involvement in a project that successfully overturned a negative CHMP opinion, resulting in EU approval. After his time at Scotia, Rob took up a post at Quintiles (Edinburgh) as a programme manager, pre-clinical services. He had responsibility for advising on suitable pre-clinical development programmes for Sponsor's drug candidates, agreeing programme costs and managing these programmes through to Phase II Proof-of-Concept within a CRO environment. Rob moved to ProStrakan (now Kyowa Kirin) in 2002. He initially worked as a product development team leader, which required him to direct global multidisciplinary project teams. This role extended from the traditional development phase through to coordination of launch planning in both EU and US. He gained extensive experience in a number of therapeutic areas including: Cancer breakthrough pain Biologic for t-cell lymphoma Parkinson's disease Chemotherapy-induced nausea and vomiting, post-operative nausea and vomiting Testosterone replacement, Pain associated with anal fissures Calcium and vitamin D supplementation Latterly, Rob rose to the position of vice president, head of project management where he continued to head up the Project Management team in the UK based ProStrakan entity of Kyowa Kirin. He was also invited to join the ‘G-DO IT' program (Global Development Organisation Incubation Team), which was a Tokyo based team designed to promote globalisation of the various development functions based in Japan, US, UK, South Korea and China. This team recommended and implemented improvements to optimise global development across Asia, US and Europe to enable Kyowa Kirin to achieve its goal of becoming a Global Specialty Pharma company. Following a successful career at ProStrakan/Kyowa Kirin, Rob set-up Syncrovex Consulting Ltd (incorporated February 2013) to provide Project Leadership/Management support to the pharmaceutical industry. Since that time he has supported small/medium pharma companies in a variety of projects including Project Management/Leadership support for projects in: Alzhiemer's Disease Acute Myeloid Lymphoma Parkinson's Disease X-linked hypophosphotaemia Emergency naloxone medical device. Rob's full career history can be viewed on his LinkedIn profile via this link: Rob LinkedIn Experience Profile